Deciphering breast cancer heterogeneity and tumor microenvironment with correlative imaging
Dauer: 60 Monate, Fördersumme: € 698.870
Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy
Dauer: 48 Monate, Fördersumme: € 799.510
Therapeutic targeting of EGFR in colorectal cancer as a novel approach to predict and enhance tumor antigenicity and response to checkpoint inhibitors
Dauer: 54 Monate, Fördersumme: € 999.500